Infliximab As a First Choice Therapy in Children with Newly Diagnosed Cronhn’s Disease ( CD ) Promotes Long-Term Sustained Remission and Alters the Course of the Disease / ) E., Romeo; F., Viola; DE ANGELIS, Gian Luigi; A., Vernuccio; V., Pannone; B., Bizzarri; O., Borrelli; S., Cucchiara. - In: GASTROENTEROLOGY. - ISSN 0892-1601. - 130:(2006).
Infliximab As a First Choice Therapy in Children with Newly Diagnosed Cronhn’s Disease ( CD ) Promotes Long-Term Sustained Remission and Alters the Course of the Disease
DE ANGELIS, Gian Luigi;
2006-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
